Zobrazeno 1 - 10 of 20 pro vyhledávání: '"F. H. J. Gmelig Meyling"'
1
Immunoglobulin G antibodies against deamidated-gliadin-peptides outperform anti-endomysium and tissue transglutaminase antibodies in children2 years age
Autor: A, Mubarak, F H J, Gmelig-Meyling, V M, Wolters, F J W, Ten Kate, R H J, Houwen
Publikováno v: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 119(12)
To investigate the usefulness of deamidated-gliadin-peptides-antibodies in the diagnosis of celiac disease, serology was tested in 212 children suspected with celiac disease who had undergone a small-intestinal-biopsy. For deamidated-gliadin-peptides
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1e8ef3eba3d0378d01cb0fc7ccd16e7d
https://pubmed.ncbi.nlm.nih.gov/22085366
Zobrazit plný text záznamu
2
T cells in cardiac allograft vasculopathy are skewed to memory Th-1 cells in the presence of a distinct Th-2 population
Autor: N. de Jonge, F. H. J. Gmelig Meyling, R.A. de Weger, E. Siera-de Koning, J. van Kuik, M.E.I. Schipper, M.F.M. van Oosterhout, D.F. van Wichen, M. C. Hagemeijer
Cardiac allograft vasculopathy (CAV) in heart transplantation (HTx) patients remains the major complication for long-term survival, due to concentric neointima hyperplasia induced by infiltrating mononuclear cells (MNC). Previously, we showed that ac
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcde2bde8382ee54ca07dcf620067e31
https://dspace.library.uu.nl/handle/1874/32251
Zobrazit plný text záznamu
3
IL-4 promotor gene polymorphism in heart transplantation
Autor: M. G. J. Tilanus, J. van Kuik, Femke J Bijlsma, N. de Jonge, F. H. J. Gmelig Meyling, R.A. de Weger, A.H. Bruggink
Publikováno v: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 20(2)
test. Results: Overall survival was borderline significantly different between all groups (OKT3: 52.4%, F-ATG: 44.3 %, THG: 67.5% and BT563: 51.8%; p 0.095). Causes of death were different between the four groups. OKT3 treated patients had the highes
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2258d8e0c66e765a2a1dbcef30b682da
https://pubmed.ncbi.nlm.nih.gov/11250229
Zobrazit plný text záznamu
4
Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease
Autor: F. H. J. Gmelig-Meyling, J.A. van Roon, F.P.J.G. Lafeber, J. W. J. Bijlsma, C. M. Verhoef, J. L. A. M. Van Roy, O. Huber-Bruning
Publikováno v: Annals of the rheumatic diseases, 56(11), 656-660. BMJ Publishing Group
Objectives—To compare peripheral type 1 (T1) and type 2 (T2) T cell activities in rheumatoid arthritis (RA) patients with that found for osteoarthritic (OA) patients and healthy controls and to correlate peripheral T1/T2 cell activity in RA with pa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4df3760353daa44a8236bb07918b155
https://pubmed.ncbi.nlm.nih.gov/9462167
Zobrazit plný text záznamu
5
Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4
Autor: J. W. J. Bijlsma, J.A. van Roon, F.P.J.G. Lafeber, J. L. A. M. Van Roy, F. H. J. Gmelig-Meyling
Publikováno v: Arthritis and rheumatism, 39(5), 829-835. John Wiley and Sons Inc.
Objective. Inflammation-induced articular cartilage degradation is a major problem in rheumatoid arthritis (RA). Type 1 T cell activity (characterized by interferon-γ/interleukin-2 [IL-2] production), and consequently, the production of the proinfla
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df5219b80d1505748d5594c8c54f8330
https://pure.amc.nl/en/publications/prevention-and-reversal-of-cartilage-degradation-in-rheumatoid-arthritis-by-interleukin10-and-interleukin4(d8a3e473-0c29-4fbb-b2d9-3c3a9d779d3b).html
Zobrazit plný text záznamu
7
Soluble CD8 and CD25 in serum of patients after heart transplantation
Autor: A. Van Der Meulen, P. L. J. Wijngaard, N. de Jonge, Henk-Jan Schuurman, F. H. J. Gmelig Meyling
Publikováno v: Clinical and experimental immunology. 97(3)
SUMMARYTo evaluate the diagnostic value of serum cytokine levels and cytokine receptor levels in the diagnosis of acute rejection after heart transplantation, we measured soluble CD8 and soluble CD25 in the serum of heart transplant recipients. The r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5eb3e50b1be2f6dbbcd9d6985208c35
https://pubmed.ncbi.nlm.nih.gov/8082307
Zobrazit plný text záznamu
9
Monitoring rejection after heart transplantation: cytoimmunological monitoring on blood cells and quantitative birefringence measurements on endomyocardial biopsy specimens
Autor: J. A. Gimpel, F. H. J. Gmelig Meyling, G. Jambroes, A. Van Der Meulen, P. L. J. Wijngaard, H. J. Schuurman
Publikováno v: Journal of clinical pathology. 43(2)
Cytoimmunological monitoring and quantitative birefringence measurements were used as potential aids in diagnosing acute rejection after heart transplantation instead of histopathological assessment of the endomyocardial biopsy specimen alone. Cytoim
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fa3ca538041420fdff8772441d5d72d
https://pubmed.ncbi.nlm.nih.gov/2318989
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje